USP Annual Meeting & Related Meetings

Quality of Manufactured Medicines, Quality of Care, and International Health

September 25–28, 2007
Hyatt Regency Tampa • Tampa, Florida

(Revised 4/04/2007)

Track Session Presentations

Wednesday, September 26, 2007

8:00 a.m. – 10:00 a.m.

Opening General Session  (7.9MB)

10:30 a.m. – 12:30 p.m.

Session I

Track I: Quality of Manufactured Medicines –Monographs and Reference Standards
Counterfeits – US Perspective  (3.8MB)

Track II:

Quality of Manufactured Medicines – General Chapters and Performance Testing
Performance Testing for Dosage Forms  (3.4MB)

Track III:

Quality of Manufactured Medicines – Biologics and Biotechnology
Analysis and Design of Bioassays  (1MB)

Track IV:

Quality of Care
Medication Safety Topics  (2.2MB)

Track V:

International Health
No Session Offered

2:00 p.m. – 4:00 p.m.

Session II

Track I: Quality of Manufactured Medicines –Monographs and Reference Standards
To be announced

Track II:

Quality of Manufactured Medicines – General Chapters and Performance Testing
The Performance Verification Test  (1.8MB)

Track III:

Quality of Manufactured Medicines –Biologics and Biotechnology
Excipients for Biotechechnology Products  (2.3MB)

Track IV:

Quality of Care
Good Naming Practices Prevent Medication Errors  (1.9MB)

Track V:

International Health
No Session Offered

Thursday, September 27, 2007

8:00 a.m. – 10:00 a.m.

General Session  (2.1MB)

10:30 a.m. – 12:30 p.m.

Session III

Track I:

Quality of Manufactured Medicines –Monographs and Reference Standards
Uncertainty in Reference Standards  (933KB)

Track II:

Quality of Manufactured Medicines – General Chapters and Performance Testing
Excipient Performance/Functional Related Characteristics  (6.2MB)

Track II:

Quality of Manufactured Medicines – General Chapters and Performance Testing
Impurities – Residual Solvents  (4.3MB)

Track III:

Quality of Manufactured Medicines – Biology and Biotechnology
Process and Ancillary Materials  (2.6MB)

Track IV:

Quality of Care
No session offered

Track V:

International Health
Global Procurement for Medicines: Quality Considerations  (2.2MB)

1:30 p.m. – 3:30 p.m.

Session IV

Track I:

Quality of Manufactured Medicines – Monographs and Reference Standards
Additives and Impurities in Excipients  (722KB)

Track II:

Quality of Manufactured Medicines – General Chapters and Performance Testing
International Harmonization  (2.3MB)

Track II:

Quality of Manufactured Medicines – General Chapters and Performance Testing
Impurities – Heavy Metals and Organic Impurities  (940KB)

Track III:

Quality of Manufactured Medicines – Biologics and Biotechnology
Horizontal Standards/Reagents  (1.2MB)

Track IV:

Quality of Care
No Session Offered

Track V:

International Health
Counterfeits – International Perspective  (5.6MB)

4:00 p.m. – 5:00 p.m.

Closing General Session  (2.2MB)